(NYSE: RVTY) Revvity's forecast annual revenue growth rate of 3.5% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 4.82%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.9%.
Revvity's revenue in 2025 is $2,798,467,000.On average, 6 Wall Street analysts forecast RVTY's revenue for 2025 to be $330,783,174,194, with the lowest RVTY revenue forecast at $330,122,024,778, and the highest RVTY revenue forecast at $331,492,841,948. On average, 6 Wall Street analysts forecast RVTY's revenue for 2026 to be $345,060,333,679, with the lowest RVTY revenue forecast at $343,888,232,766, and the highest RVTY revenue forecast at $346,685,581,944.
In 2027, RVTY is forecast to generate $368,665,666,056 in revenue, with the lowest revenue forecast at $367,944,274,971 and the highest revenue forecast at $370,018,491,976.